Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/99309
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wijesundara, D. | - |
dc.contributor.author | Xi, Y. | - |
dc.contributor.author | Ranasinghe, C. | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Frontiers in Immunology, 2014; 5(Aug):1-7 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.issn | 1664-3224 | - |
dc.identifier.uri | http://hdl.handle.net/2440/99309 | - |
dc.description.abstract | It has been well-established that type I interferons (IFN-Is) have pleiotropic effects and play an early central role in the control of many acute viral infections. However, their pleiotropic effects are not always beneficial to the host and in fact several reports suggest that the induction of IFN-Is exacerbate disease outcomes against some bacterial and chronic viral infections. In this brief review, we probe into this mystery and try to develop answers based on past and recent studies evaluating the roles of IFN-Is in infection and immunity as this is vital for developing effective IFN-Is based therapeutics and vaccines. We also discuss the biological roles of an emerging IFN-I, namely IFN-ε, and discuss its potential use as a mucosal therapeutic and/or vaccine adjuvant. Overall, we anticipate the discussions generated in this review will provide new insights for better exploiting the biological functions of IFN-Is in developing efficacious therapeutics and vaccines in the future. | - |
dc.description.statementofresponsibility | Danushka Kumara Wijesundara, Yank Xi and Charani Ranasinghe | - |
dc.language.iso | en | - |
dc.publisher | Frontiers | - |
dc.rights | Copyright: © 2014 Wijesundara, Xi and Ranasinghe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | - |
dc.source.uri | http://dx.doi.org/10.3389/fimmu.2014.00412 | - |
dc.subject | IFN-ε | - |
dc.subject | human immunodeficiency virus | - |
dc.subject | interferon immunity | - |
dc.subject | type I interferons | - |
dc.subject | vaccine adjuvants | - |
dc.title | Unravelling the convoluted biological roles of type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine design | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.3389/fimmu.2014.00412 | - |
dc.relation.grant | http://purl.org/au-research/grants/nhmrc/525431 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Wijesundara, D. [0000-0002-0740-8362] | - |
Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_99309.pdf | Published version | 498.26 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.